Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3390/medsci6020051 http://scihub22266oqcxt.onion/10.3390/medsci6020051 C6024649!6024649!29904028     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Med+Sci+(Basel) 2018 ; 6 (2): ä Nephropedia Template TP {{tp|p=29904028|t=2018. Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis |pdf=|usr=}}{{29904028}} gab.com Text Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis JO: Med Sci (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=29904028 #FOAvip Idiopathic pulmonary fibrosis (IPF), a devastating progressive interstitial lung disease (ILD) with no known cause, is the most common and deadly of the idiopathic interstitial pneumonias. With a median survival of 3?5 years following diagnosis, IPF is characterized by a progressive decline in lung function and quality of life in most patients. Prognostic factors recognized classically that influence mortality include functional, clinical and radiological parameters. However, in recent years, there has also been progress in the knowledge of genetic factors and biomarkers that may be useful in the prognostic evaluation of these patients. On the other hand, the monitoring of the disease throughout its evolution is key to improving the prognosis of the patients, as it allows for taking therapeutic measures based on this evolution, even early remission for lung transplantation. This article reviews the main prognostic factors of the disease, as well as the most useful way to monitor the disease follow-up. Twit Text FOAVip Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis ????Med Sci (Basel) http://www.kidney.de/pget.php?&tw=1&pmid=29904028 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29904028 #FOAvip English Wikipedia <ref>{{Cite pmid|29904028}}</ref> Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis #MMPMID29904028 Fernández Fabrellas E; Peris Sánchez R; Sabater Abad C; Juan Samper G Med Sci (Basel) 2018[Jun]; 6 (2): ä PMID29904028show ga Idiopathic pulmonary fibrosis (IPF), a devastating progressive interstitial lung disease (ILD) with no known cause, is the most common and deadly of the idiopathic interstitial pneumonias. With a median survival of 3?5 years following diagnosis, IPF is characterized by a progressive decline in lung function and quality of life in most patients. Prognostic factors recognized classically that influence mortality include functional, clinical and radiological parameters. However, in recent years, there has also been progress in the knowledge of genetic factors and biomarkers that may be useful in the prognostic evaluation of these patients. On the other hand, the monitoring of the disease throughout its evolution is key to improving the prognosis of the patients, as it allows for taking therapeutic measures based on this evolution, even early remission for lung transplantation. This article reviews the main prognostic factors of the disease, as well as the most useful way to monitor the disease follow-up. äPrognosis and Follow-Up of Idiopathic Pulmonary Fibrosis (epmc).pdf DeepDyve Pubget Overpricing